Despite the coronavirus and its variants, stocks continue to climb a wall of worry, as investors overcome a succession of fears and obstacles. Read More
Analyst Articles
We’re witnessing greater market volatility amid the latest COVID mutation. As 2022 looms, here are the risks and rewards for investors. Read More
When mainstream influencers aren't creating false gods, they're sowing panic. Amid COVID-generated volatility, it pays to be contrarian. Read More
Despite renewed fears about COVID, the U.S. economy continues to beat growth projections for jobs and manufacturing. Read More
The outbreak of the COVID mutation requires caution, not impulsive selling. Here are three simple moves to help get you through the crisis. Read More
Europe's largest economy is poised to legalize recreational pot, with ramifications for investors and the thriving segment of illicit sales. Read More
COVID's Omicron variant is spooking the markets. Underlying conditions remain bullish, but you need to take protective steps. Read More
The emergence of yet another coronavirus variant is weighing on stocks. But here’s why investors should remain optimistic. Read More
While large Silicon Valley names hog the headlines, this little-known small-cap tech player in the Boston area is poised for outsized growth. Read More
The global emergency over crude oil underscores the rapid ascendancy of electric vehicles as alternatives to petroleum-based transportation. Read More